H. Wathieu

发表

Drug Metabolism in Preclinical Drug Development: A Survey of the Discovery Process, Toxicology, and Computational Tools.

Sivanesan Dakshanamurthy, Naiem T Issa, Henri Wathieu, 2017, Current drug metabolism.

Differential prioritization of therapies to subtypes of triple negative breast cancer using a systems medicine method

Naiem T. Issa, H. Wathieu, S. Byers, 2017, Oncotarget.

Evaluation of deacetylase inhibition in metaplastic breast carcinoma using multiple derivations of preclinical models of a new patient-derived tumor

H. Wathieu, S. Elliott, B. Collins-Burow, 2019, bioRxiv.

Evaluation of deacetylase inhibition in metaplastic breast carcinoma using multiple derivations of preclinical models of a new patient-derived tumor

H. Wathieu, S. Elliott, B. Collins-Burow, 2019, bioRxiv.

A Case of Pseudothrombotic Microangiopathy Associated with Pernicious Anemia

H. Wathieu, Kristin M. Bateman, 2021, Journal of General Internal Medicine.

Expression of Novel Kinase MAP3K19 in Various Cancers and Survival Correlations.

D. Drewry, H. Wathieu, S. Okpechi, 2022, Frontiers in bioscience.

DrugGenEx-Net: a novel computational platform for systems pharmacology and gene expression-based drug repurposing

H. Wathieu, S. Byers, N. Issa, 2016, BMC Bioinformatics.

In-depth characterization of a new patient-derived xenograft model for metaplastic breast carcinoma to identify viable biologic targets and patterns of matrix evolution within rare tumor types

H. Wathieu, E. Flemington, E. Martin, 2021, Clinical and Translational Oncology.

NEK5 activity regulates the mesenchymal and migratory phenotype in breast cancer cells

K. Nephew, D. Drewry, W. Zuercher, 2021, Breast Cancer Research and Treatment.

A novel chemo-phenotypic method identifies mixtures of salpn, vitamin D3, and pesticides involved in the development of colorectal and pancreatic cancer

H. Wathieu, S. Byers, S. Dakshanamurthy, 2022, Ecotoxicology and environmental safety.

Harnessing Polypharmacology with Computer-Aided Drug Design and Systems Biology.

H. Wathieu, S. Byers, S. Dakshanamurthy, 2016, Current pharmaceutical design.

Evaluation of liver kinase B1 downstream signaling expression in various breast cancers and relapse free survival after systemic chemotherapy treatment

D. Drewry, H. Wathieu, B. Collins-Burow, 2021, Oncotarget.

Correction: Evaluation of deacetylase inhibition in metaplastic breast carcinoma using multiple derivations of preclinical models of a new patient-derived tumor

H. Wathieu, S. Elliott, B. Collins-Burow, 2021, PLoS ONE.

DrugGenEx-Net: a novel computational platform for systems pharmacology and gene expression-based drug repurposing

Henri Wathieu, Dakshanamurthy Sivanesan, Stephen W. Byers, 2016, BMC Bioinformatics.